ERBB2 and breast cancer: BECN1 knock-in mutation also reduces amyloid oligomers and improves cognitive function in a mice model of Alzheimer’s disease (Rocchi et al., 2017), and reduces HER2-driven breast cancer tumorigenesis in mice (Vega-Rubin-de-Celis et al., 2018).